SMARCA4 and neoplasm: The most affected marker was ARID1A, whereby 47% of the cases had a loss of staining in tumor cells as well as stromal tissue and lymphocytes, which are the internal controls (See Fig. 3d), followed by PMS2 (12%), and BRG1 (14%).